Overview

Safety Study of Galantamine in Tic Disorders

Status:
Terminated

Trial end date:
2007-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the safety, tolerability and efficacy of galantamine in tic disorders. The impact of galantamine on commonly associated behaviors (i.e. attention, obsessions, etc.) will also be examined.

Phase:

Phase 4

Details

Lead Sponsor:

Parkinson's Disease and Movement Disorders Center

Collaborator:

Ortho-McNeil Neurologics, Inc.

Treatments:

Galantamine